Cherwell increases commitment to pharmaceutical microbiology in Republic of Ireland
Ritchie Mooney, Cherwell Laboratories’ new Sales Specialist, is based in the Republic of Ireland.
Ritchie Mooney appointed as Sales Specialist, based in the Republic of Ireland.
Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, are continuing their drive to improve support for pharmaceutical microbiology in the Republic of Ireland. As part of this initiative, Cherwell has appointed Ritchie Mooney as Sales Specialist, based in the Republic of Ireland. To further establish their commitment to the Irish market, Cherwell will also be supporting and attending the Pharmig conference on the 18 May in Cork, Ireland.
Prior to joining Cherwell Laboratories, Ritchie has worked for both manufacturers and distributors in the Life Science and associated industries for almost 20 years. During his time with Veltek Associates in particular, Ritchie acquired a good knowledge of Environmental Monitoring sampling and equipment, along with fogging systems and sterile disposable products for cleaning and disinfection purposes. Commenting on his new position at Cherwell, Ritchie said: “I am excited to be joining Cherwell and I am really looking forward to helping customers in Ireland with our Redipor Prepared Media in relation to various applications, such as environmental monitoring, product sterility testing, operator validation and process validation, amongst others.”
Andrew Barrow, Sales Manager of Cherwell, commented: “With Cherwell now shipping Redipor product directly to customers in the Republic of Ireland, we welcome Ritchie to the team. His previous experience within the industry; good understanding and appreciation of GMP and sterile production; along with his knowledge of the latest industry guidelines; means that Ritchie is able to fully understand and help us satisfy customer needs.”
Ritchie Mooney and Andrew Barrow will both be representing Cherwell at the Pharmig conference held on the 18 May at Fota Island Hotel, Cork. They will be on hand to offer practical advice on Cherwell’s products and their applications within environmental monitoring, sterility testing of products, and process validation. The event will highlight Current Hot Topics in Pharmaceutical Microbiology. Topics covered include: data integrity and new expectations; EM incubation strategies; contamination control and regulatory requirements. Also, at the same venue, Pharmig is hosting a second event on 19 May Focusing on Control of Pharmaceutical Water Systems Topics will include, Annex 1 and ISO 14644 updates; data integrity and disinfectant efficacy testing.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.